Abstract:Abstract Aims/hypothesis Our aim was to characterise the in-depth metabolic response to aerobic exercise and the impact of residual pancreatic beta cell function in type 1 diabetes. We also aimed to use the metabolome to distinguish individuals with type 1 diabetes with reduced maximal aerobic capacity in exercise defined by $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak . Methods Thirty participants with type 1 diabetes (≥3 years duration) and 30 control participants were recruited. Groups did not differ in age or sex. After quantification of peak stimulated C-peptide, participants were categorised into those with undetectable ( 200 pmol/l) residual beta cell function. Maximal aerobic capacity was assessed by $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak test and did not differ between control and type 1 diabetes groups. All participants completed 45 min of incline treadmill walking (60% $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak ) with venous blood taken prior to exercise, immediately post exercise and after 60 min recovery. Serum was analysed using targeted metabolomics. Metabolomic data were analysed by multivariate statistics to define the metabolic phenotype of exercise in type 1 diabetes. Receiver operating characteristic (ROC) curves were used to identify circulating metabolomic markers of maximal aerobic capacity ( $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak ) during exercise in health and type 1 diabetes. Results Maximal aerobic capacity ( $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak ) inversely correlated with HbA 1c in the type 1 diabetes group ( r 2 =0.17, p =0.024). Higher resting serum tricarboxylic acid cycle metabolites malic acid (fold change 1.4, p =0.001) and lactate (fold change 1.22, p =1.23×10 −5 ) differentiated people with type 1 diabetes. Higher serum acylcarnitines (AC) (AC C14:1, F value=12.25, p =0.001345; AC C12, F value=11.055, p =0.0018) were unique to the metabolic response to exercise in people with type 1 diabetes. C-peptide status differentially affected metabolic responses in serum ACs during exercise (AC C18:1, leverage 0.066; squared prediction error 3.07). The malic acid/pyruvate ratio in rested serum was diagnostic for maximal aerobic capacity ( $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak ) in people with type 1 diabetes (ROC curve AUC 0.867 [95% CI 0.716, 0.956]). Conclusions/interpretation The serum metabolome distinguishes high and low maximal aerobic capacity and has diagnostic potential for facilitating personalised medicine approaches to manage aerobic exercise and fitness in type 1 diabetes. Graphical Abstract

Responses to Low- and High-Intensity Exercise in Adolescents with Type 1 Diabetes in Relation to Their Level of VO2 Max

Continuous moderate and intermittent high-intensity exercise in youth with type 1 diabetes: Which protection for dysglycemia?

Management of Glycemia during Acute Aerobic and Resistance Training in Patients with Diabetes Type 1: A Croatian Pilot Study

Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI)

Acute effects of exercise on macro- and microvasculature in individuals with type 1 diabetes - a secondary outcome analysis

Association of HbA1c with VO2max in Individuals with Type 1 Diabetes: A Systematic Review and Meta-Analysis

Training under normoxia and normobaric hypoxia in patients with type 1 diabetes

Effects of different exercise programs and minimal detectable changes in hemoglobin A1c in patients with type 2 diabetes

595-P: Exercise Training Improves Cardiorespiratory Parameters but Not VO2peak in People with Type 2 Diabetes

The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes

Effects of high-intensity intermittent exercise on glucose and lipid metabolism in type 2 diabetes patients: a systematic review and meta-analysis

Sex-Related Glycemic and Cardiovascular Responses After Continuous and Interval Aerobic Sessions in Patients With Type 1 Diabetes: A Randomized Crossover Study

In Amateur Athletes With Type 1 Diabetes, a 9-Day Period of Cycling at Moderate-to-Vigorous Intensity Unexpectedly Increased the Time Spent in Hyperglycemia, Which Was Associated With Impairment in Heart Rate Variability

High-intensity, but not moderate-intensity, exercise increases post-exercise rate of fat oxidation in type 2 diabetics

A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes

Influence of Anaerobic Exercise in Type 1 Diabetes Mellitus Biomarkers: ASystematic Review

Characteristics of Selected Somatic and Motor Abilities of Youth Soccer Players with Diabetes Type 1 Treated with Insulin Pump Therapy

Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabetes—A Randomized Cross-Over Trial

Alteration in sympathoadrenergic activity at rest and during intense exercise despite normal aerobic fitness in late pubertal adolescent girls with type 1 diabetes

Exercise and Type 1 Diabetes (T1DM)

Relation between energy intake and glycemic control in physically active young adults with type 1 diabetes